Blacksburg, VA, United States of America

Jocelyn N Browning


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Jocelyn N. Browning

Introduction

Jocelyn N. Browning is an accomplished inventor based in Blacksburg, Virginia, known for her significant contributions to medical diagnostics. With one patented invention to her credit, she has made strides in differentiating infectious strains that impact treatment decisions.

Latest Patents

Jocelyn holds a patent for an innovative method that provides accurate and rapid differentiation of the outbreak strain ribotype 027 from other possible strains through stool samples. This method aids healthcare professionals in making informed decisions regarding treatment options. Her patent emphasizes the importance of Cell wall protein V (CwpV), which showcases a conserved cell wall binding domain across strains and a variable antigenically distinct domain. By utilizing antibodies against the specific region of ribotype 027 in CwpV, diagnostic tests can effectively detect ribotype 027 in culture or fecal samples.

Career Highlights

Jocelyn N. Browning is currently employed at TechLab, Inc., where she brings her expertise in microbiology and invention to the forefront of medical research. Through her work, she plays a critical role in developing diagnostic tools that enhance patient care and outbreak management.

Collaborations

In her professional journey, Jocelyn collaborates closely with colleagues such as Manli Y. Davis and Krista A. Williams. These partnerships exemplify the collaborative spirit inherent in scientific research, contributing to innovative advancements in the field of medical diagnostics.

Conclusion

Jocelyn N. Browning's contributions to the field of medical diagnostics through her innovative patent reflect her dedication and expertise. As she continues to work at TechLab, Inc. alongside her talented colleagues, her impact on healthcare and treatment options for infectious diseases will be profoundly felt in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…